Diabetes

Altitude reduces the risk of diabetes due to red blood cells acting as the primary glucose sink during hypoxia, a 2026 study has found.

Metabolic and bariatric surgery offers greater cardiovascular protection than GLP-1 receptor agonists, a 2026 systematic review and meta-analysis has found.

Prescribing patients with type 2 diabetes SGLT-2 inhibitors much earlier in the treatment process could prevent around 17,000 deaths in the UK, new NICE guidance suggests.

A review of 41 trials finds only two assessed dietary intake with GLP 1 receptor agonists, underscoring a critical gap in nutrition research.

GLP-1RAs are associated with a reduced risk of aneurysmal rupture in high-risk patient populations, a 2026 study has found.

Tirzepatide proves superior to semaglutide in weight reduction and improving glycaemic indices, a 2026 network meta-analysis has found.

Maternal diabetes is associated with an increased epilepsy risk in offspring, a 2026 cohort study has found.

Gut microbiota dysbiosis might contribute to the development of diabetic retinopathy through the gut-eye axis, according to a 2026 systematic review and meta-analysis.